Could Recursion Pharmaceuticals Be the Next Big Artificial Intelligence (AI) Stock?

Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.
InfoWorld

Will JavaFX return to Java?

Just as a proposal to return JavaFX to the Java Development Kit has drawn interest in the OpenJDK community, Oracle too says ...

Mojang is finally revealing all of Minecraft: Java Edition's code after 16 years to "make it quicker and easier for modders to create and improve mods"

Well over a decade has passed since the release of Mojang 's monumental sandbox game Minecraft, with countless mods dropping ...
Visual Studio Magazine

Microsoft's New Java & AI Video Series Helps Devs Get Started with GenAI

Microsoft introduced a new video series that teaches Java developers how to build generative AI applications using modern ...
TipRanks on MSN

Roche Exercises Option with Recursion Pharmaceuticals

An announcement from Recursion Pharmaceuticals ( ($RXRX) ) is now available. On October 29, 2025, Recursion Pharmaceuticals announced that Roche ...

'Java Man,’ the first Homo erectus discovered, is finally going home

Excavated with colonial labor and shipped to the Netherlands, the famous fossil is being repatriated to Indonesia along with ...
Investing

Recursion Pharma CEO Gibson sells $604k in shares

Recursion Pharmaceuticals (NASDAQ:RXRX), a $2.3 billion market cap biotech company currently trading at $5.31, saw Chief Executive Officer Christopher Gibson sell 100,000 shares of Class A Common ...
The Motley Fool

Where Will Recursion Pharmaceuticals Be in 5 Years?

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...